{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9403253", "DateCompleted": {"Year": "1998", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1018-8665", "JournalIssue": {"Volume": "195 Suppl 2", "PubDate": {"Year": "1997"}}, "Title": "Dermatology (Basel, Switzerland)", "ISOAbbreviation": "Dermatology"}, "ArticleTitle": "Antiseptic efficacy of disinfecting solutions in suspension test in vitro against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in pressure sore wounds after spinal cord injury.", "Pagination": {"StartPage": "36", "EndPage": "41", "MedlinePgn": "36-41"}, "Abstract": {"AbstractText": ["In pressure sore wounds after spinal cord injury, methicillin-resistant Staphylococcus aureus can be detected in 2% of the cases. The elimination of the germ is the aim of the treatment. Pressure sore wounds are an often found complication after spinal cord injury. For local treatment five commercially available antiseptics for the skin and mucous membrane were tested in vitro. The method used is a modified qualitative and quantitative suspension test. The antiseptics were tested without and with addition of 5% albumin in order to simulate the conditions of the wound in vivo. The results show a superior efficacy of the povidone-iodine preparations. Betadine, probably due to the higher concentration, is more efficacious than Braunol; chlorhexidine is sufficiently efficacious without the addition of albumin. These results still have to be confirmed by in vivo studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Swiss Paraplegic Center, Nottwil, Switzerland."}], "LastName": "Michel", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Z\u00e4ch", "ForeName": "G A", "Initials": "GA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Dermatology", "NlmUniqueID": "9203244", "ISSNLinking": "1018-8665"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents, Local"}, {"RegistryNumber": "0", "NameOfSubstance": "Biguanides"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Imines"}, {"RegistryNumber": "0", "NameOfSubstance": "Iodophors"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Quaternary Ammonium Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Serum Albumin"}, {"RegistryNumber": "322U039GMF", "NameOfSubstance": "polihexanide"}, {"RegistryNumber": "85H0HZU99M", "NameOfSubstance": "Povidone-Iodine"}, {"RegistryNumber": "MOR84MUD8E", "NameOfSubstance": "chlorhexidine gluconate"}, {"RegistryNumber": "OZE0372S5A", "NameOfSubstance": "octenidine"}, {"RegistryNumber": "R4KO0DY52L", "NameOfSubstance": "Chlorhexidine"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Anti-Infective Agents, Local"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Biguanides"}, {"QualifierName": [], "DescriptorName": "Chamomile"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "therapeutic use"], "DescriptorName": "Chlorhexidine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Escherichia coli"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Escherichia coli Infections"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Imines"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Iodophors"}, {"QualifierName": [], "DescriptorName": "Methicillin Resistance"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Povidone-Iodine"}, {"QualifierName": ["drug therapy", "microbiology"], "DescriptorName": "Pressure Ulcer"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Pseudomonas Infections"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pseudomonas aeruginosa"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Pyridines"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Quaternary Ammonium Compounds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serum Albumin"}, {"QualifierName": ["microbiology"], "DescriptorName": "Skin"}, {"QualifierName": ["complications"], "DescriptorName": "Spinal Cord Injuries"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Staphylococcal Infections"}, {"QualifierName": ["drug effects"], "DescriptorName": "Staphylococcus aureus"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1997", "Month": "12", "Day": "24", "Hour": "0", "Minute": "1"}, {"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9403253", "10.1159/000246028"]}}]}